Health Catalyst, Inc

Health Catalyst, Inc

1.27
EUR
0.00
(0.00%)
-2.43EPS
118.04MMarket Cap
Mar 02Next Earn

Total Valuation

EUR

As of September 30, 2026, Health Catalyst, Inc. carries a market capitalization of 118.04M, placing it among publicly traded companies globally. Its enterprise value stands at 62.25M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap118.04M
Enterprise Value62.25M

Important Dates

Health Catalyst, Inc.'s next confirmed earnings release is scheduled for March 2, 2027.

Earnings Date3/2/2027

Share Statistics

As of September 30, 2026, Health Catalyst, Inc. has 76.16M shares outstanding.

Shares Outstanding76.16M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 0.47, and the price-to-book ratio stands at 0.92.

PS Ratio0.47
PB Ratio0.92
P/TBV Ratio1.59
P/FCF Ratio5.24
P/OCF Ratio4.80

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 0.26 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 62.25M versus a market cap of 118.04M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.26

Financial Position

As of September 30, 2026, Health Catalyst, Inc. maintains a current ratio of 1.70, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 10.82, indicating elevated leverage, while an interest coverage ratio of -8.07 demonstrates limited ability to service its debt obligations.

Current Ratio1.70
Quick Ratio1.54
Debt / Equity10.82
Debt / EBITDA-0.12
Interest Coverage-8.07

Financial Efficiency

EUR

Over the twelve months ended September 30, 2026, Health Catalyst, Inc. posted a negative return on equity (ROE) of -84.64, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -49.02, reflecting losses generated across the asset base. The company generates approximately 200,138.73 in revenue per employee across its workforce of 1,200.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-84.64
Return on Assets (ROA)-49.02
Revenue Per Employee200,138.73
Employee Count1,200.00

Taxes

EUR

Over the twelve months ended September 30, 2026, Health Catalyst, Inc. recorded 630,844.50 in income tax expense. The company reported a pretax loss of -177.67M and -178.31M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax630,844.50

Stock Price Statistics

EUR

As of the close on November 17, 2026, Health Catalyst, Inc.'s stock has declined approximately 34.87% over the past 52 weeks. The 50-day moving average sits at 1.49, while the 200-day moving average is 1.45.

52-Week Price Change-34.87%
50-Day Moving Average1.49
200-Day Moving Average1.45

Income Statement

EUR

Over the twelve months ended September 30, 2026, Health Catalyst, Inc. generated 240.17M in revenue and converted that into -178.31M in net income, yielding earnings per share of -2.43. EBITDA reached -117.52M, while operating income came in at -25.66M.

Revenue240.17M
Gross Profit118.00M
Operating Income-25.66M
Pretax Income-177.67M
Net Income-178.31M
EBITDA-117.52M
EBIT-157.84M
Earnings Per Share (EPS)-2.43

Balance Sheet

EUR

As of September 30, 2026, Health Catalyst, Inc. holds 69.69M in cash and equivalents against 13.90M in total debt, resulting in a net debt position of -47.42M. Total book value stands at 128.45M, with working capital of 48.37M providing operational flexibility.

Cash & Cash Equivalents69.69M
Total Debt13.90M
Net Debt-47.42M
Equity (Book Value)128.45M
Book Value Per Share1.69
Working Capital48.37M

Cash Flow

EUR

Health Catalyst, Inc. produced 23.67M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -1.94M in capital expenditures, free cash flow totaled 21.72M - equivalent to 0.30 per share.

Operating Cash Flow23.67M
Capital Expenditures-1.94M
Free Cash Flow21.72M
FCF Per Share0.30

Margins

Over the twelve months ended September 30, 2026, Health Catalyst, Inc. posted a gross margin of 49.13, reflecting its pricing power and cost economics. The operating margin of -10.69 and net profit margin of -74.24 provide insight into operational efficiency.

Gross Margin49.13
Operating Margin-10.69
Pretax Margin-73.98
Profit Margin-74.24
EBITDA Margin-48.93

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 19.10, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 122.41, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Health Catalyst, Inc. shareholders.

Shareholder Yield122.41
FCF Yield19.10

Scores

As of September 30, 2026, Health Catalyst, Inc. has an Altman Z-Score of -9.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-9.48